José Luis
Vicario Moreno
José Luis Vicario Moreno-rekin lankidetzan egindako argitalpenak (10)
2024
2023
-
Rationale for combined therapies in severe-to-critical COVID-19 patients
Frontiers in Immunology, Vol. 14
2022
-
Identifying SARS-CoV-2 ‘memory’ NK cells from COVID-19 convalescent donors for adoptive cell therapy
Immunology, Vol. 165, Núm. 2, pp. 234-249
2021
-
A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol
Trials, Vol. 22, Núm. 1
-
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)
EClinicalMedicine, Vol. 39
2018
-
Characterization of the novel HLA-A*80:04 allele identified in a Spanish volunteer donor
HLA, Vol. 92, Núm. 4, pp. 245-246
2016
-
Genomic full-length sequence of two new HLA-C alleles, HLA-C*04:239 and HLA-C*05:137
HLA
-
Genomic sequence of HLA-B*41:43, a new HLA-B allele generated by an intralocus recombination mechanism
HLA, Vol. 87, Núm. 2, pp. 111-113
-
The new HLA-A*24:321 shows one conservative amino acid replacement compared with HLA-A*24:02:01
HLA, Vol. 87, Núm. 1, pp. 50-51
2015
-
A new HLA-B allele, B*49:34, sequenced in a Spanish individual
Tissue Antigens, Vol. 85, Núm. 4, pp. 293-294